First line combination therapy with interferon alfa-2b and ribavirin for chronic hepatitis C - Daily dosing versus tiw

Reiser, M. and Bussisch, P. and Grossmann, J. and Koop, K. and Schmiegel, W. (2000) First line combination therapy with interferon alfa-2b and ribavirin for chronic hepatitis C - Daily dosing versus tiw. In: The American Association for the Study of Liver Diseases (AASLD) 51st annual meeting and postgraduate courses, October 27-31, 2000, Dallas, Texas, USA.

Full text not available from this repository.
Item Type: Conference or Workshop Item (UNSPECIFIED)
Additional Information: Artikel in Hepatology 2000 Oct;32(4 Pt 2)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin I
Depositing User: Petra Gürster
Date Deposited: 06 May 2021 05:17
Last Modified: 06 May 2021 05:17
URI: https://pred.uni-regensburg.de/id/eprint/42168

Actions (login required)

View Item View Item